Stockreport

Why Analysts Say the CytomX Story Is Evolving After Recent Clinical Momentum and Price Target Hike [Yahoo! Finance]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF CytomX Therapeutics has recently seen its consensus analyst price target rise from $6.14 to $7.07 per share, reflecting growing optimism about the company's outlook as i [Read more]